Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

95 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q3 2024.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 43.6M shares of 60.7M outstanding shares and own 71.88% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.9M shares), FRANKLIN RESOURCES INC (3.55M shares), Sands Capital Ventures, LLC (3.42M shares), BlackRock, Inc. (2.33M shares), Rock Springs Capital Management LP (2.3M shares), FMR LLC (2.03M shares), VANGUARD GROUP INC (1.93M shares), MILLENNIUM MANAGEMENT LLC (1.83M shares), Knollwood Investment Advisory, LLC (1.63M shares), and Alyeska Investment Group, L.P. (940K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.